Claryx builds a hospital-focused infectious disease surveillance platform that sequences genomes from confirmed patient infections to identify related cases and detect outbreaks. The company links outbreak cases to likely environmental sources by comparing clinical genomes against a continuously updated digital twin of the hospital microbiome, generated from air, water, and surface sampling using proprietary, cost-efficient chemistry.
Leadership & Board
Key Executives
FounderKurt Hackenberger
FounderDirk Hackenberger
Current Number of Employees9
Current LinkedIn Followers334
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$4M
Total Amount Raised$4M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$4M
Latest Funding Amount$4M
Latest Funding RoundPre-Seed
Latest Funding RoundPre-Seed
Post-Money Valuation―
Post-Money Valuation―
Funding Round
Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Aug 12, 2026
Pre-Seed
$3.50M
―
Similar Companies
A snapshot of private companies similar to Claryx, helping you discover and navigate related company profiles.